Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

During the Trading Day
12.18 +0.58 / +5.00%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.75 +0.57 / +4.68%
 
Volume: 46.9K

Today’s Trading

Previous close11.60
Today’s open11.73
Day’s range11.69 - 12.44
Volume1,512,576
Average volume (3 months)809,398
Market cap$490.5M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+83.33%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+48.05%
P/E ratio9.4
Price/Sales10.47
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...+0.19+2.68%
KPTIKaryopharm Therapeut...+1.26+9.42%
CARACara Therapeutics In...+1.00+5.39%
SPPISpectrum Pharmaceuti...-0.40-5.70%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$50.2M
Annual profit (last year)$20.2M
Net profit margin40.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

Partner Offers